Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP863706.RAAZOZnajsKZeL-wpgtgSHfrd4fhoqB4T5t-uMgwMH-tA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP863706.RAAZOZnajsKZeL-wpgtgSHfrd4fhoqB4T5t-uMgwMH-tA130_assertion type Assertion NP863706.RAAZOZnajsKZeL-wpgtgSHfrd4fhoqB4T5t-uMgwMH-tA130_head.
- NP863706.RAAZOZnajsKZeL-wpgtgSHfrd4fhoqB4T5t-uMgwMH-tA130_assertion wasGeneratedBy ECO_0000203 NP863706.RAAZOZnajsKZeL-wpgtgSHfrd4fhoqB4T5t-uMgwMH-tA130_provenance.
- NP863706.RAAZOZnajsKZeL-wpgtgSHfrd4fhoqB4T5t-uMgwMH-tA130_assertion wasDerivedFrom befree-2016 NP863706.RAAZOZnajsKZeL-wpgtgSHfrd4fhoqB4T5t-uMgwMH-tA130_provenance.
- NP863706.RAAZOZnajsKZeL-wpgtgSHfrd4fhoqB4T5t-uMgwMH-tA130_assertion SIO_000772 2121299 NP863706.RAAZOZnajsKZeL-wpgtgSHfrd4fhoqB4T5t-uMgwMH-tA130_provenance.
- NP863706.RAAZOZnajsKZeL-wpgtgSHfrd4fhoqB4T5t-uMgwMH-tA130_assertion evidence source_evidence_literature NP863706.RAAZOZnajsKZeL-wpgtgSHfrd4fhoqB4T5t-uMgwMH-tA130_provenance.
- NP863706.RAAZOZnajsKZeL-wpgtgSHfrd4fhoqB4T5t-uMgwMH-tA130_assertion description "[Interferon alfa-2c in chronic myelogenous leukemia (CML): hematologic, cytogenetic and molecular-genetic response of patients with chronic phase CML previously resistant to therapy with interferon gamma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863706.RAAZOZnajsKZeL-wpgtgSHfrd4fhoqB4T5t-uMgwMH-tA130_provenance.